ABOUT US

OUR VISION

To be continually recognised by our customers as the source of superior, cost‑effective, innovative solutions and technologies within infection prevention across all key critical areas of Hand & Skin asepsis, Hard Surface disinfection & Cleaning, Enzymatic instrument reprocessing, instrument disinfection and Environmental Hygiene.

WHAT WE DO

Novapharm Research has been recognised as a global leader in the skin asepsis category of infection control for over three decades. The company has an extensive patent portfolio and a series of platform technologies which have been recognised for their technological originality achieving functional advancements throughout the world. Novapharm’s expertise spans formulation, chemistry and microbiology together with dispensing and packaging.

 

Novapharm has powerful technology in hard surface disinfection and the pre-cleaning and re-processing of medical instruments, thus, an end-to-end infection control platform. Novapharm enjoys several accreditations including ISO13485.

 

Novapharm has developed a series of the world’s leading skin asepsis product ranges for our customers, including Microshield, Avagard and Asepti. We have also published multiple papers on microbial control and sat on numerous industry & technical committees.

Novapharm enjoys a broad Patent portfolio as well as a large portfolio of regulatory files and approvals in key global markets and has a strategic focus on work-flow and cost efficiency ‘in use’. There is an ongoing focus on new product pipelines together with a unique capability of adapting to customer technical needs across all business units so as to innovate and develop unique, broad IP based solutions that continue to “raise the bar” by delivering next generation / superior products.

scientist-hands-with-microscope-examinin

WHAT WE OFFER

Side-by-side performance comparisons against competitors with respect to:

  • Cleaning efficacy on artificial and ISO 15883-5 challenge soils

  • Enzyme activity and storage stability analysis

  • Materials compatibility validations and testing

  • Biofilm removal efficacy

  • Full range of disinfection efficacy testing against common and emerging bacteria and viruses

  • Customised biocidal, cleaning and material compatibility validations

  • Support for worldwide tender documentation

  • Life cycle analysis of formulations and/or packaging

OUR COLLABORATIONS

Our clients also benefit from Novapharm’s extensive collaboration with many institutions like:

  • University of NSW 

  • University of Melbourne

  • Robert Koch Institute (RKI) 

  • UK Health Protection Agency

  • CJD Surveillance Unit (UK)

logo.png
the-university-of-melbourne-logo-png-tra
RKI-Logo_b4cxoa.gif
Brainstorming Session

THE TECHNOLOGY GROUP

Novapharm, through its senior board member connections with Aeris Environmental, Nanosonics and the Regional Health Care Group, have access to over 100 researchers, chemists, microbiologists and engineers with Novapharm and across Aeris, Nanosonics and the Regional Health Care Group.

Picture1.png
TECHGROUP-01.png